Ad Alert


Another cure-all supplement? NAD refers company to the FTC and FDA for further review.

PhytoZon, a dietary supplement marketed by Multilevel Marketing – a way of distributing products or services in which the distributors earn income from their own retail sales and from retail sales made by their direct and indirect recruits., American Dream Nutrition LLC, and advertised as “Phyto Nutrition from the Amazon Rain Forest” makes a variety of claims about how it can help users with a range of illnesses.

phytozon bottleIf you’ve never heard of “phyto nutrition” then we at are on the same page. “Phyto” is a Greek word indicating plant. The company advertises “With Over 500 Hundred ingredients specific Research and Clinical Studies, PhytoZon was scientifically formulated to Enhance, Promote and Support” everything from mental clarity to heart health. Testimonials claim that the supplement helped manage illnesses ranging from breast cancer to chronic kidney disease.

But the Council for Responsible Nutrition took issue with certain claims and referred the company to The National Advertising Division (NAD) is the advertising industry’s self-regulatory body administered by the Council of Better Business Bureaus., which noted that it was concerned that “by couching the claims as establishment claims by referencing ‘research’ and ‘clinical’ studies’ can convey to consumers the message that the claimed benefits have been proven by rigorous and reliable scientific study.”

When the company declined to participate in NAD’s inquiry into its challenged advertising claims, NAD referred it to the FTC and FDA for investigation.

For more on’s coverage of the supplement industry, click here.

Our Ad Alerts are not just about false and deceptive marketing issues, but may also be about ads that, although not necessarily deceptive, should be viewed with caution. Ad Alerts can also be about single issues and may not include a comprehensive list of all marketing issues relating to the brand discussed.

You Might Be Interested In


Ad Alert


FDA targets supplement sellers on Amazon making unapproved disease-treatment claims.